Ke X, McKnight RA, Maniar LE, Sun Y, Callaway CW, Majnik A, Lane RH, Cohen SS. IUGR increases chromatin-remodeling factor Brg1 expression and binding to GR exon 1.7 promoter in newborn male rat hippocampus. Am J Physiol Regul Integr Comp Physiol 309: R119 -R127, 2015. First published May 13, 2015 doi:10.1152/ajpregu.00495.2014.-Intrauterine growth restriction (IUGR) increases the risk for neurodevelopment delay and neuroendocrine reprogramming in both humans and rats. Neuroendocrine reprogramming involves the glucocorticoid receptor (GR) gene that is epigenetically regulated in the hippocampus. Using a wellcharacterized rodent model, we have previously shown that IUGR increases GR exon 1.7 mRNA variant and total GR expressions in male rat pup hippocampus. Epigenetic regulation of GR transcription may involve chromatin remodeling of the GR gene. A key chromatin remodeler is Brahma-related gene-1(Brg1), a member of the ATPdependent SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeling complex. Brg1 regulates gene expression by affecting nucleosome repositioning and recruiting transcriptional components to target promoters. We hypothesized that IUGR would increase hippocampal Brg1 expression and binding to GR exon 1.7 promoter, as well as alter nucleosome positioning over GR promoters in newborn male pups. Further, we hypothesized that IUGR would lead to accumulation of specificity protein 1 (Sp1) and RNA pol II at GR exon 1.7 promoter. Indeed, we found that IUGR increased Brg1 expression and binding to GR exon 1.7 promoter. We also found that increased Brg1 binding to GR exon 1.7 promoter was associated with accumulation of Sp1 and RNA pol II carboxy terminal domain pSer-5 (a marker of active transcription). Furthermore, the transcription start site of GR exon 1.7 was located within a nucleosome-depleted region. We speculate that changes in hippocampal Brg1 expression mediate GR expression and subsequently trigger neuroendocrine reprogramming in male IUGR rats.
UTEROPLACENTAL INSUFFICIENCY (UPI) leads to intrauterine growth restriction (IUGR) and complicates up to 4 -6% of all pregnancies in developed countries (13) . IUGR predisposes affected newborns toward poor neurological outcomes and impaired neuroendocrine programming (18, 20, 46, 67, 71) . Neuroendocrine programming of the hypothalamo-pituitary axis (HPA) axis is regulated, in part, by the hippocampus (24, 40) . Multiple studies suggest that IUGR-induced neuroendocrine reprogramming involves altered glucocorticoid receptor (GR) expression in the hippocampus and dysregulation of HPA axis reactivity (24, 34, 42, 43, 74, 75, 80) . Regulation of GR expression involves regulation at both transcriptional and translational levels. GR transcriptional control partially relies on epigenetic regulation of multiple alternative initiation sites that are tissue-specific (38, 48, 49) .
The GR gene is highly conserved between humans and rats. The GR gene is very complex and produces multiple mRNA variants ( Fig. 1 ). In the rat, GR gene, exon 1 contains 11 variants that result in the same protein product. The variants differ from one another through different promoter usage and transcription initiation sites. In the rat, as well as other mammals, exon 1 variants are tissue-specific (48, 69, 82) . The expression of the exon 1.7 variant is highly abundant in the hippocampus, but it is absent in other tissues (48) . Exon 1.7 plays an important role in regulating hippocampus GR expression and programming the HPA axis sensitivity (14, 48, 50, 77) . Interestingly, UPI-induced IUGR specifically increases GR exon 1.7 mRNA variant expression in male rat pup hippocampus (34) . However, the epigenetic mechanism that determines the specific upregulation of GR exon 1.7 variant remains unknown.
Epigenetic regulation of gene expression includes alterations in chromatin architecture. One mechanism of chromatin remodeling involves ATP-dependent SWItch/Sucrose NonFermentable (SWI/SNF) chromatin-remodeling complexes in which Brahma-related gene 1 (Brg1) protein is the central catalytic ATPase (73) . Brg1 is an essential regulator for neurogenesis in the vertebrate nervous system during development (63) . Brg1 uses energy derived from ATP hydrolysis to actively alter the structure and/or position of the nucleosome of target promoters and subsequently affects gene transcription. Furthermore, Brg1 recruits transcription factors (TFs), such as specificity protein 1 (Sp1) and RNA polymerase II (RNA pol II) to the promoter of target genes and activates transcription (47) . Sp1 is a zinc finger TF that binds to guanine-cytosine (GC)-rich motifs of many promoters. GR promoters contain many GCrich motifs that are the consensus sequences for Sp1 binding. Sp1 regulates GR gene expression through binding to the Sp binding site on GR promoters in the developing brain (14, 68) . Sp1 is generally a transcriptional activator (16, 70) and enhances transcription by RNA pol II (56, 61) . In addition, RNA pol II activity requires phosphorylation of its COOH-terminal repeat domain (CTD) (6) .
The CTD of RNA pol II coordinates the entire transcription cycle of RNA pol II (10, 21) . Posttranslational modification of the CTD by phosphorylation provides a means to recruit histone modifiers and chromatin remodeling complexes to influence transcription initiation, elongation, and termination (35, 66) . The pattern of phosphorylation on individual CTDs can vary due to differential phosphorylation of Ser-2 vs. Ser-5 residues (57). Phosphorylation of Ser-5 residues predominates at 5= of the gene and is related to transcription initiation and capping enzyme recruitment that is necessary for mRNA maturation (1, 35, 57) .
The production of GR mRNA and subsequent mRNA maturation involves a complex coordination of multiple factors, including chromatin remodeling and recruitment of transcriptional machinery. We hypothesized that IUGR would increase hippocampal Brg1 expression and binding to GR exon 1.7 promoter in newborn rat pups. We hypothesized further that increased Brg1 binding would be associated with accumulations of Sp1 and RNA pol II CTD pSer-5 in GR exon 1.7 promoter, as well as repositioning of nucleosomes over GR promoters. To test these hypotheses, we used a well-characterized rat model of UPI-induced IUGR (31, 33, 34) , which results in significantly lighter placental mass and pup body weights compared with controls (54, 64) . IUGR rat pups grow up to develop metabolic disorders and impaired neurodevelopment (4, 8, 12, 39, 62, 79) . Furthermore, circulating corticosterone and testosterone levels are elevated in male IUGR rat pups at birth and postnatal day 21 (2, 3, 53) , suggesting a sex-specific impairment of the HPA axis. In addition, this impaired HPA axis is associated with increased GR gene expression in the hippocampus (34) .
MATERIALS AND METHODS

Animals
All procedures were approved by the University of Utah Institutional Animal Care and Use Committee and are in accordance with the American Physiological Society's guiding principles (1a) . Surgical methods have been described previously (27, 34) . Briefly, on day 19.5 of gestation (term gestation in the rat is 21.5 days), pregnant rats were anesthetized with intraperitoneal xylazine (8 mg/kg) and ketamine (40 mg/kg), and both uterine arteries were ligated to induce IUGR in the pups. Control animals underwent identical anesthesia without surgical procedure. Day 0 pups (DOL 0) were delivered by caesarian section at term. Brains from male pups were either quickly removed and dissected to isolate hippocampus for molecular study or processed for histological evaluation (33) .
Real-Time RT-PCR
Hippocampal mRNA levels of Brg1 were measured using real-time RT-PCR, as previously described (31, 34) . The primers and probes were designed using Primer Express (Applied Biosystems, Foster, CA) with the reporter dye FAM and the quencher dye TAMRA (Table 1) . Real-time RT-PCR quantification was then performed using GAPDH as an internal control (32) (33) (34) . GAPDH primer and probe sequences are listed in Table 1 (n ϭ 6 litters).
Immunoblot
Hippocampal levels of Brg1 protein were quantified using immunoblot with anti-Brg1 antibody (sc-10768; Santa Cruz Biotechnology, Santa Cruz, CA), as previously described (31, 34) . GAPDH (no. 
Immunohistochemistry and Immunofluorescence
Immunohistochemistry (IHC) was used to localize Brg1 expression in the hippocampus, as previously described (32, 34) . Immunofluorescence triple labeling was used to colocalize Brg1 and GR in neurons and glia cells. Briefly, adjacent coronal sections from the same brains were deparaffinized, rehydrated, and blocked with 3% normal goat serum for 1 h at room temperature to block nonspecific binding sites. Sections were then incubated with a mouse IgG monoclonal anti-GR (1:500, ab9568; Abcam, Cambridge, MA) at 4°C overnight. After washing three times in PBS for 10 min at room temperature, sections were then incubated with DyLightTM Cy3-conjugated affinipure donkey anti-mouse IgG (1:1,000; Jackson ImmunoResearch, West Grove, PA) at room temperature for 1 h. Following washing, sections were incubated with 3% normal mouse serum at room temperature for 1 h. Sections were then washed and subjected to unconjugated goat anti-mouse IgG (1:50; Jackson ImmunoResearch) at room temperature for 1 h to block extract antigen left from first labeling. Sections were washed and incubated with rabbit polyclonal anti-Brg1 (1:1,000; sc-10768; Santa Cruz), and either mouse monoclonal anti-NeuN (mature neuronal marker, 1:1,000, MAB377; Chemicon) or mouse monoclonal antiadenomatous polyposis coli (APC, a glial marker that detects both oligodendrocytes and astrocytes; 1:1,000, ab16794; Abcam) mix in PBS-Tween at 4°C overnight. After washing, sections were incubated with a secondary fluorescence-labeled DyLightTM 649-conjugated affinipure goat antimouse IgG and DyLightTM 488-conjugated affinipure goat antirabbit IgG (1:1,000; Jackson ImmunoResearch) mix for 1 h at room temperature. Sections were then washed, air-dried, and covered with coverslips using Fluoromount-G mounting medium (Southern Biotech, Birmingham, AL). Sections were imaged with the Nikon's A1 Nikon's A1 multiphoton laser-scanning confocal microscope (Nikon Instruments/Americas) (n ϭ 4 litters).
Chromatin Immunoprecipitation and Real-Time PCR
Hippocampi were dissected from control and IUGR rat brains at DOL 0. Chromatin immunoprecipitation (ChIP) with antibodies against Brg1 (sc-10768x), Sp1(sc-59x), RNA pol II (sc-899x; Santa Cruz Biotechnology), and RNA pol II CTD phosphor Ser-5 (no. 39749; Active Motif, Carlsbad, CA) were performed using SimpleChIP Enzymatic Chromatin IP kit (no. 9003, Cell Signaling, Beverly, MA). Real-time PCR was used to quantitate the amount of DNA from the GR promoter regions of exons 1.4 to 1.11. An intergenic sequence 250 kb upstream of the IGF-1 gene was used as an internal control (11, 34) . The PCR primers are listed in Table. 1. Two control experiments were performed simultaneously with our ChIP experiments. First, we performed a "mock" ChIP that included input but did not use antibody. Second, we performed a ChIP that used an anti-rabbit secondary antibody as a negative control (n ϭ 6 litters).
Target Nucleosome Core DNA Preparation and High-Throughput Sequencing
Nucleosome core DNA isolation. To study the positions that nucleosomes occupied, hippocampi of two pups from the same litter were pooled into each group (n ϭ 4 litters). Nucleosome core DNA was isolated as previously described by Gracey et al. (15) . Briefly, 30 mg of ground tissue was treated with 500 units micrococcal nuclease (MNase), and DNA was extracted with phenol/chloroform. Mononucleosome DNA was gel purified by 2% agarose gel, ligated to linkers compatible with the Illumina HiSeq 2000 platform and PCRenriched.
Biotinylated dsDNA probe generation and selective hybridization. A biotin-labeled 1.5-kb probe that spanned from GR intron 1.4 to exon 1.10 portion of the vector was generated and mixed with amplified Illumina-linked nucleosome core DNA populations from DOL 0 rat hippocampi.
Capture of target nucleosome core DNA. One microgram of mononucleosome core DNA fragment was ligated with Illumina adaptors using TruSeq DNA sample preparation kit (cat. no. PE-940-200; Illumina). The target nucleosome core DNA was captured as previously described (15) . Captured target nucleosome core DNA was amplified and sent to the High Throughput Genomics Core Facility in the University of Utah for high-throughput sequencing. Nucleosome positioning was determined across exons 1.5 to exon 1.10.
Nucleosome coverage calculation. Novoalign was used to align the Illumina sequence reads to the rat genome (rn4), and only perfect matches were used for further analysis. The target region (chr18: 32462537-chr18:32461060) was selected from the raw alignments, and duplicates were removed. SAMtools was used to calculate the depth of coverage on the target region. Normalized nucleosome coverage index values were generated by dividing the number of sequence reads at a particular base pair by the average coverage for the probe (the total sequence reads for a particular probe divided by the length of the probe). Coverage plots were generated using R to display the number of overlapping nucleosomes observed at each base in the promoters of GR exon 1.5 to 1.10.
Statistics
All data presented are expressed as the mean percentage of control Ϯ SE. We used the Mann-Whitney U-test to determine statistical significance for data sets involving Brg1 expression, and Brg1, as well as Sp1, RNA pol II occupancy in GR exon 1.7 region. Statistical significance was accepted as P Ͻ 0.05.
RESULTS
We have previously reported that IUGR increases hippocampal GR expression at birth and postnatal day 21 in male pups (34) . Increased GR expression is associated with increased GR exon 1.7 mRNA variant expression and accumulation of histone H3 lysine 4 trimethylation (H3K4me3) at GR exon 1.7 promoter region (34) . This present study investigated one potential molecular mechanism that results in upregulation of GR exon 1.7 and total GR in male pup hippocampus.
IUGR Increased Hippocampal Brg1 Expression and Binding to GR Exon 1.7 Promoter
IUGR significantly increased rat hippocampal Brg1 mRNA levels to 113.6 Ϯ 4.9% of control values at DOL 0 (P Ͻ 0.05). Furthermore, IUGR significantly increased hippocampal Brg1 protein levels to 197.3 Ϯ 37.3% of control values (P Ͻ 0.05) (Fig. 2) . IHC staining suggested that differences in Brg1 expression were not confined to a particular hippocampal subregion (Fig. 3, A and B) . Brg1 colocalized with GR in neurons and glial cells (Fig. 3, C-J) . Importantly, our ChIP analysis showed that IUGR significantly increased Brg1 occupancy at GR exon 1.7 promoter to 129.2 Ϯ 7.7% of control values (P Ͻ 0.05) (Fig. 4A) .
IUGR Increased the Occupancy of Sp1 and RNA pol II CTD phosphor-Ser-5 at GR Exon 1.7 Promoter
IUGR significantly increased Sp1 occupancy at GR promoters 1.4 (135 Ϯ 10% of Control, P Ͻ 0.05), 1.5 (130 Ϯ 11% of Control, P Ͻ 0.05), 1.7 (144 Ϯ 6% of Control, P Ͻ 0.05), and 1.8 (135 Ϯ 9% of Control, P Ͻ 0.05), with 1.7 showing the most accumulation (Fig. 4B) . Similarly, IUGR significantly increased RNA pol II CTD Ser-5 occupancies at GR promoters 1.4 (140 Ϯ 11% of Control, P Ͻ 0.05), 1.5 (140 Ϯ 11% of Control, P Ͻ 0.05) and 1.7 (153 Ϯ 8% of Control, P Ͻ 0.05), with 1.7 showing the most accumulation (Fig. 4D) . However, IUGR did not affect total RNA pol II accumulation at GR promoters compared with control (Fig. 4C) .
Hippocampal-Enriched Exon 1.7 Transcription Start Site Was Positioned Within a Nucleosome-Depleted Region and IUGR Did not Affect Nucleosome Positioning Over GR Promoters
Nucleosome coverage plots are the measures of nucleosome occupancy and positioning from high-throughput sequencing data to display nucleosome patterns (15, 30) . The nucleosome reads of the experiment need to be extended to the average nucleosome length in that experiment (always between 140 and 170 bp) (30) . For the map, the normalized nucleosome occupancy at every base pair is calculated as the log-ratio between the number of reads that cover that base pair and the average number of reads per base pair across promoters of GR exon 1.5 to 1.10 regions.
Our results show that the transcription start sites (TSSs) of exon 1.6 and hippocampal-enriched exon 1.7 were positioned at a nucleosome-depleted region (NDR). The NDRs were not evident for the TSSs of exon 1.5, 1.8, and 1.10. The linker regions between 1.7 and 1.8, as well as 1.9 and 1.10, were masked by the reads from 1.7 to 1.9. Finally, IUGR had a lower effect on the nucleosome patterns over GR promoters of exon 1.5 to 1.10 than controls (Fig. 5 ).
DISCUSSION
Our novel findings in newborn male rat hippocampus are 1) UPI-induced IUGR increased Brg1 expression in association with Brg1 accumulation in GR exon 1.7 promoter; 2) IUGR increased Sp1 and RNA pol II CTD pSer-5 occupancies in GR promoters, especially in GR exon 1.7; 3) TSS of GR exon 1.7 was located within a NDR. These findings occur within the context of significant changes in male hippocampal GR exon 1.7 expression and epigenetic modifications (34) .
Our study focuses on the impact of IUGR upon Brg1 expression and the involvement of Brg1 on epigenetic regulation of GR gene expression in developing rat hippocampus. Brg1 regulates gene transcription epigenetically by affecting the chromatin structure of target promoters (26, 72) . In addition, Brg1 interacts with GR for GR-regulated transactivation on target genes (5) . We and others have demonstrated that GR expression is epigenetically regulated by early life stress (34, 48, 49, 76 -78) . Our study is the first to demonstrate that IUGR affects hippocampal Brg1 expression and binding in the context of altered gene expression and epigenetic structure. To our knowledge, despite the pivotal role of Brg1 and the SWI/SNF complex in regulating gene expression, this is the first evidence of an early life event such as IUGR affecting Brg1 expression and gene-specific binding in the brain. We speculate that Brg1 plays a role in the IUGR-induced programming of hippocampal GR expression.
Brg1 interacts with several transcription factors, including Sp1, to activate target genes (9, 22, 23, 41, 47, 51) . Because Brg1 does not contain a sequence-specific DNA-binding domain, the selective recruitment of the SWI/SNF complex to target genes depends on protein-protein interactions through Brg1 and other transcription factors or transcription regulators (28, 29, 51) . Studies have shown that Brg1 regulated Sp1 and Sp3 binding to the matrix metalloproteinase-2 (MMP-2) promoter by increasing the association of Sp1, decreasing the association of Sp3, and enhancing the recruitment of activating protein 2 (AP-2) and RNA pol II (47) . Moreover, Brg1 is recruited to the proximal secreted protein acidic and rich in cysteine (SPARC) gene promoter region through an interaction with Sp1 that enhances SPARC gene promoter activity (81) . In our study, we found that UPI-induced IUGR increased Sp1 binding to GR exon 1.7 promoter concurrently with Brg1 binding and increased GR exon 1.7 expression. In contrast, IUGR induced by maternal hypoxia in neonatal rats led to decreased hippocampal Sp1 binding to GR exon 1.7 promoter in association with decreased GR and exon 1.7 mRNA variant expressions (14) . Taken together, these data suggest that Sp1 binding to GR exon 1.7 promoter is necessary for GR exon 1.7 transcription.
Sp1 activates target gene transcription through recruitment of RNA pol II to the promoter (83) . In our study, IUGR significantly increased accumulation of the active form of RNA pol II CTD pSer-5 but not total RNA pol II in GR promoters, particularly in exon 1.7, suggesting that IUGR selectively increases transcription initiation at this particular start site rather than any of the other potential TSSs within the hippocampus. Furthermore, the accumulation of RNA pol II CTD pSer-5 is noteworthy because it is not only necessary for transcription initiation and mRNA maturation (1, 17, 55) but also is required for chromatin remodeling by recruitment of the histone methyltransferase Set1-containing complex (17, 55) . Set1 methylates H3K4 specifically in nucleosomes (7, 19, 36) . Recruitment of Set1 to 5= ends of genes results in a peak of H3K4me3 around promoters (37, 45, 52, 58) . We have previously shown that IUGR increases accumulation of H3K4me3 at GR 1.7 promoter in association with increased GR 1.7 mRNA variant expression in male hippocampus (34) . We speculate that increased accumulation of RNA pol II CTD pSer-5 at GR exon 1.7 promoter may recruit Set1 and lead to this accumulation of H3K4me3 at GR exon 1.7 promoter region in male IUGR hippocampus. We found the recruitment of Sp1 and RNA pol II CTD pSer-5 occurred not only at GR exon 1.7 promoter, but also across several promoters, including GR exon 1.4 and 1.5. However, we did not find increased transcription levels of GR exon 1.4 and 1.5 by IUGR in the brain in this model (34) . These data suggest that other factors such as Brg1 may be required to trigger transcription initiation for these TSSs in the hippocampus. While all three GR exon 1 variants are expressed in the hippocampus, GR exon 1.7 exhibits considerable transactivational activity (48) . In addition, we and others have shown that GR exon 1.7 is selectively vulnerable in hippocampus during development and adulthood (34, 48, 76, 77) . We speculate that Brg1 interacts with Sp1 and subsequently recruits transcription machinery components to GR exon 1.7 promoter that results in transcription activation in male IUGR hippocampus.
Our finding of the TSS of GR exon 1.7 located at a NDR is important because NDR in proximal promoters of genes provides unobstructed access to sequence-specific TFs. NDR also provides access to the basal transcription machinery, subsequently facilitating transcription (25, 44, 59, 60) . GR exon 1.7 is the only mRNA variant upregulated in male IUGR hippocampus throughout early life in rat (34) . The fact that the TSS of GR exon 1.7 is located within a NDR makes it likely to become the initiation site for GR transcription in this model. In addition, NDR is a Brg1-enriched region. Brg1 has been shown to affect nucleosomes, phasing in the region surrounding TSS in vivo and alters the structure and/or position of nucleosome of target promoters (26, 72) . In this study, however, IUGR did not affect the position of nucleosomes on the GR promoters in male hippocampus. These data make sense given that GR is a stress response gene, and the IUGR-induced changes in GR expression is an adaptive response. Similar findings in vitro showed that Brg1 does not change the position of nucleosomes on the MMP-2 promoter, yet it is required for maximal transcription of the gene by recruiting Sp1 and RNA pol II to the promoter (47) . We speculate that the NDR of GR exon 1.7 promoter provides a platform for Brg1 binding that results in the recruitment of Sp1 and RNA pol II CTD pSer-5 and leads to the assembly of transcription machinery. One limitation of our study is that we did not study dissected hippocampal subfields but rather used whole hippocampus. Nevertheless, our IHC data support uniform effects across the various hippocampal areas. In addition, we used homogenized whole hippocampus for each group, thus minimizing the effects of any one cell population within a study group. Caution is also necessary when attempting to apply data from animal models to human pathophysiology. The fetal rat brain is physiologically immature relative to the human, and the insult imposed on the fetal rat in our model of UPI is severe and specific. In contrast, the timing and impact of UPI experienced by humans range across a continuum.
Perspectives and Significance
The present work has identified in the newborn male IUGR rat hippocampus altered expression of a key chromatin remodeling enzyme Brg1 and its binding to the promoter of GR exon 1.7, which is hippocampal-specific and vulnerable to perinatal insults. The Brg1-related recruitment of Sp1 and RNA pol II CTD pSer-5 to GR exon 1.7 promoter suggests that GR exon 1.7 is actively transcribed in this model. We speculate that upregulation of Brg1 mediates GR expression in male IUGR rat hippocampus, which subsequently may affect the programming of the HPA axis that complicates the IUGR phenotype. Importantly, the present results set the stage for future investigation that Brg1 may have programming implications beyond GR gene and the central nervous system. Brg1-related transcriptional regulation could be a potential mechanism for studying other critical genes that are epigenetically regulated during development. Further investigation is required to establish the role of Brg1 in epigenetic regulation of GR gene throughout brain development and adulthood in this IUGR animal model.
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